Cancer Clinical Trial -HonorHealth Research Institute-HRI-Vemurafenib-Sorafenib-001

Cancer

Status:

open

ClinicalTrials.gov:

NCT05068752

Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

Drug

Vemurafenib, Sorafenib

Phase

Phase II

Condition

Pancreatic

Keywords

KRAS G12D